Document is current
Any future updates will be listed below
-
Authors
Gibson, Richard M.
Nickel, Gabrielle
Crawford, Michael
Kyeyune, Fred
Venner, Colin
Nankya, Immaculate
Nabulime, Eva
Ndashimye, Emmanuel
Poon, Art F. Y.
Salata, Robert A.
Kityo, Cissy
Mugyenyi, Peter
Quiñones-Mateu, Miguel E.
Arts, Eric J. https://orcid.org/0000-0002-4880-7968
-
Funding
Funding for this research was provided by:
Fogarty International Center (D43-TW000011, D43-TW009780)
National Institutes of Health (AI49170, P30 AI036219)
Canadian Institutes of Health Research
- License Information
-
More Information
Article History
Received: 18 August 2017
Accepted: 22 November 2017
First Online: 4 December 2017
Ethics approval and consent to participate
: Clinical and virological data were obtained from patient care database at the JCRC under IRB approval (EM10-07) for HIV-1 drug resistance testing.
: Not applicable
: E.J.A developed and patented the technology used in AfriPOLA. R.M.G and M.E.Q-M developed DEEPGEN™HIV. There are no further patents, products in development or marketed products to declare.
